Cryoprecipitate Transfusion After Cardiac Surgery.

Area of Science:

• Cardiovascular Surgery
• Transfusion Medicine
• Critical Care Medicine

Background:

• The role of cryoprecipitate transfusion in cardiac surgery outcomes remains unclear.
• Understanding predictors and outcomes of cryoprecipitate use is crucial for patient management.

Purpose of the Study:

• To investigate predictors of postoperative cryoprecipitate transfusion in cardiac surgery patients.
• To determine the association between cryoprecipitate transfusion and patient outcomes.

Main Methods:

• Utilized the Medical Information Mart for Intensive Care III and IV databases.
• Included adult patients undergoing cardiac surgery, employing propensity score matching for cryoprecipitate-treated patients and controls.
• Assessed in-hospital mortality, infection, acute kidney injury, and length of stay as primary and secondary outcomes.

Main Results:

• 2.35% of 12,043 eligible patients received cryoprecipitate post-cardiac surgery.
• Propensity score matching identified 195 cryoprecipitate recipients and 743 controls.
• Cryoprecipitate transfusion was not significantly associated with in-hospital mortality, infection, or acute kidney injury.

Conclusions:

• Cryoprecipitate was administered to sicker patients with increased bleeding, but its use did not correlate with adverse outcomes.
• Larger, multicenter studies are recommended to further clarify the safety and utilization of cryoprecipitate in cardiac surgery.